Due to the site upgrade, your MY ACCOUNT logins will need to be updated. Please access Forgot Your Password to make this change. If you do not have an account, click here.

Alpha-Lipoic Acid in combination with medication helps patient survive pancreatic cancer that metastasized to the liver

Feb 27, 2006
A patient with pancreatic cancer that had metastasized to the liver was told by a reputable university oncology center in October 2002 that there was little hope for his survival. The patient visited an integrative medical department and was put on a combination of intravenous Alpha-Lipoic Acid and low dose naltrexone along with a healthy lifestyle program. Today, January 2006, he is back at work, free from symptoms, and without appreciable progression of his malignancy. The combination had no toxic adverse effects. The report, published by physicians at New Mexico State University at Las Cruces and The Department of Family Practice at the University of Illinois at Chicago is published in the March 2006 issue of the journal Integrative Cancer Therapies.

Commentary by Jerry Hickey, R.Ph.

Goji berry may aid diabetes

Lycium barbarum, commonly known as Goji berry, has been reported to decrease blood sugar levels. In this study the effects of Goji berry on insulin resistance and blood fats was studied in rats that are used in diabetes research. The rats doomed to develop diabetes were fed a high fat diet and were treated with the antibiotic streptozotocin; an antibiotic that quickly causes non-insulin dependent diabetes. Giving a group of the diabetic rats Goji berry extract for 3 weeks resulted in a significant decrease in plasma triglyceride levels and weight. The Goji berry markedly decreased plasma cholesterol levels and fasting plasma insulin levels. Goji berry also markedly decreased postprandial glucose during an oral glucose tolerance test while significantly improving insulin sensitivity. The study was performed at the Department of Biological Engineering at Yanshan University, and is published in the December 2005 issue of the Journal of the Pharmaceutical Society of Japan.